ID   SRMS_HUMAN              Reviewed;         488 AA.
AC   Q9H3Y6;
DT   17-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   12-OCT-2022, entry version 169.
DE   RecName: Full=Tyrosine-protein kinase Srms;
DE            EC=2.7.10.2 {ECO:0000269|PubMed:23822091, ECO:0000269|PubMed:29496907};
GN   Name=SRMS; Synonyms=C20orf148;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INTERACTION WITH DOK1,
RP   DOMAIN, PHOSPHORYLATION AT TYR-380, AND MUTAGENESIS OF TRP-223; LYS-258 AND
RP   TYR-380.
RX   PubMed=23822091; DOI=10.1111/febs.12420;
RA   Goel R.K., Miah S., Black K., Kalra N., Dai C., Lukong K.E.;
RT   "The unique N-terminal region of SRMS regulates enzymatic activity and
RT   phosphorylation of its novel substrate Dok1.";
RL   FEBS J. 280:4539-4559(2013).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH KHDRBS1 AND VIM, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF LYS-258.
RX   PubMed=29496907; DOI=10.1074/mcp.ra118.000643;
RA   Goel R.K., Paczkowska M., Reimand J., Napper S., Lukong K.E.;
RT   "Phosphoproteomics analysis identifies novel candidate substrates of the
RT   non-receptor tyrosine kinase, SRMS.";
RL   Mol. Cell. Proteomics 17:925-947(2018).
RN   [4]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-73; ARG-75; VAL-88; LEU-301; GLU-377;
RP   VAL-397; LEU-452; THR-453; LEU-457 AND THR-465.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Non-receptor tyrosine-protein kinase which phosphorylates
CC       DOK1 on tyrosine residues (PubMed:23822091). Also phosphorylates
CC       KHDRBS1/SAM68 and VIM on tyrosine residues (PubMed:29496907).
CC       Phosphorylation of KHDRBS1 is EGF-dependent (PubMed:29496907).
CC       {ECO:0000269|PubMed:23822091, ECO:0000269|PubMed:29496907}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028,
CC         ECO:0000269|PubMed:23822091, ECO:0000269|PubMed:29496907};
CC   -!- SUBUNIT: Interacts (via the SH2 and SH3 domains) with DOK1
CC       (PubMed:23822091). Interacts with KHDRBS1/SAM68 and VIM
CC       (PubMed:29496907). {ECO:0000269|PubMed:23822091,
CC       ECO:0000269|PubMed:29496907}.
CC   -!- INTERACTION:
CC       Q9H3Y6; Q99704: DOK1; NbExp=7; IntAct=EBI-8541270, EBI-1384360;
CC       Q9H3Y6; O43639: NCK2; NbExp=3; IntAct=EBI-8541270, EBI-713635;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23822091,
CC       ECO:0000269|PubMed:29496907}. Note=Localizes to punctate cytoplasmic
CC       structures. {ECO:0000269|PubMed:23822091, ECO:0000269|PubMed:29496907}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in most breast cancers (at protein
CC       level).
CC   -!- DOMAIN: The N-terminal region regulates its kinase activity.
CC       {ECO:0000269|PubMed:23822091}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SRC subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL121829; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS13525.1; -.
DR   RefSeq; NP_543013.1; NM_080823.3.
DR   AlphaFoldDB; Q9H3Y6; -.
DR   SMR; Q9H3Y6; -.
DR   BioGRID; 112603; 28.
DR   IntAct; Q9H3Y6; 16.
DR   MINT; Q9H3Y6; -.
DR   STRING; 9606.ENSP00000217188; -.
DR   BindingDB; Q9H3Y6; -.
DR   ChEMBL; CHEMBL5703; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9H3Y6; -.
DR   iPTMnet; Q9H3Y6; -.
DR   PhosphoSitePlus; Q9H3Y6; -.
DR   BioMuta; SRMS; -.
DR   DMDM; 27805732; -.
DR   MassIVE; Q9H3Y6; -.
DR   MaxQB; Q9H3Y6; -.
DR   PaxDb; Q9H3Y6; -.
DR   PeptideAtlas; Q9H3Y6; -.
DR   PRIDE; Q9H3Y6; -.
DR   ProteomicsDB; 80768; -.
DR   Antibodypedia; 29781; 194 antibodies from 25 providers.
DR   DNASU; 6725; -.
DR   Ensembl; ENST00000217188.2; ENSP00000217188.1; ENSG00000125508.4.
DR   GeneID; 6725; -.
DR   KEGG; hsa:6725; -.
DR   MANE-Select; ENST00000217188.2; ENSP00000217188.1; NM_080823.4; NP_543013.1.
DR   UCSC; uc002yfi.3; human.
DR   CTD; 6725; -.
DR   DisGeNET; 6725; -.
DR   GeneCards; SRMS; -.
DR   HGNC; HGNC:11298; SRMS.
DR   HPA; ENSG00000125508; Tissue enhanced (stomach).
DR   MIM; 617797; gene.
DR   neXtProt; NX_Q9H3Y6; -.
DR   OpenTargets; ENSG00000125508; -.
DR   PharmGKB; PA36122; -.
DR   VEuPathDB; HostDB:ENSG00000125508; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   GeneTree; ENSGT00940000161518; -.
DR   HOGENOM; CLU_000288_7_2_1; -.
DR   InParanoid; Q9H3Y6; -.
DR   OMA; RAQAKVC; -.
DR   OrthoDB; 539311at2759; -.
DR   PhylomeDB; Q9H3Y6; -.
DR   TreeFam; TF351634; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   PathwayCommons; Q9H3Y6; -.
DR   Reactome; R-HSA-8849472; PTK6 Down-Regulation.
DR   SignaLink; Q9H3Y6; -.
DR   SIGNOR; Q9H3Y6; -.
DR   BioGRID-ORCS; 6725; 13 hits in 1106 CRISPR screens.
DR   GenomeRNAi; 6725; -.
DR   Pharos; Q9H3Y6; Tchem.
DR   PRO; PR:Q9H3Y6; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9H3Y6; protein.
DR   Bgee; ENSG00000125508; Expressed in mucosa of transverse colon and 68 other tissues.
DR   Genevisible; Q9H3Y6; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0009968; P:negative regulation of signal transduction; TAS:Reactome.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cytoplasm; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; SH2 domain; SH3 domain; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN           1..488
FT                   /note="Tyrosine-protein kinase Srms"
FT                   /id="PRO_0000088160"
FT   DOMAIN          51..112
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          120..212
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          230..488
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        350
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         236..244
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         258
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         380
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:23822091"
FT   VARIANT         73
FT                   /note="R -> C (in dbSNP:rs56053583)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041831"
FT   VARIANT         75
FT                   /note="G -> R (in dbSNP:rs55863722)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041832"
FT   VARIANT         88
FT                   /note="I -> V (in dbSNP:rs35558836)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041833"
FT   VARIANT         218
FT                   /note="P -> L (in dbSNP:rs378483)"
FT                   /id="VAR_051700"
FT   VARIANT         255
FT                   /note="V -> M (in dbSNP:rs34969822)"
FT                   /id="VAR_051701"
FT   VARIANT         301
FT                   /note="V -> L (in dbSNP:rs310657)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041834"
FT   VARIANT         325
FT                   /note="P -> L (in dbSNP:rs8122355)"
FT                   /id="VAR_051702"
FT   VARIANT         377
FT                   /note="D -> E (in dbSNP:rs55838540)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041835"
FT   VARIANT         397
FT                   /note="A -> V (in dbSNP:rs6011889)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041836"
FT   VARIANT         452
FT                   /note="P -> L (in dbSNP:rs8120713)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041837"
FT   VARIANT         453
FT                   /note="A -> T (in dbSNP:rs310655)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041838"
FT   VARIANT         457
FT                   /note="V -> L (in dbSNP:rs310654)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041839"
FT   VARIANT         465
FT                   /note="S -> T (in dbSNP:rs33933649)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041840"
FT   MUTAGEN         223
FT                   /note="W->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:23822091"
FT   MUTAGEN         258
FT                   /note="K->M: Loss of kinase activity. Exhibits a diffused
FT                   cytoplasmic localization. No effect on interaction with
FT                   KHDRBS1 or VIM but abolishes tyrosine phosphorylation of
FT                   both substrates."
FT                   /evidence="ECO:0000269|PubMed:23822091,
FT                   ECO:0000269|PubMed:29496907"
FT   MUTAGEN         380
FT                   /note="Y->F: Significant reduction in phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:23822091"
SQ   SEQUENCE   488 AA;  54507 MW;  83193AD26C5F6F68 CRC64;
     MEPFLRRRLA FLSFFWDKIW PAGGEPDHGT PGSLDPNTDP VPTLPAEPCS PFPQLFLALY
     DFTARCGGEL SVRRGDRLCA LEEGGGYIFA RRLSGQPSAG LVPITHVAKA SPETLSDQPW
     YFSGVSRTQA QQLLLSPPNE PGAFLIRPSE SSLGGYSLSV RAQAKVCHYR VSMAADGSLY
     LQKGRLFPGL EELLTYYKAN WKLIQNPLLQ PCMPQKAPRQ DVWERPHSEF ALGRKLGEGY
     FGEVWEGLWL GSLPVAIKVI KSANMKLTDL AKEIQTLKGL RHERLIRLHA VCSGGEPVYI
     VTELMRKGNL QAFLGTPEGR ALRLPPLLGF ACQVAEGMSY LEEQRVVHRD LAARNVLVDD
     GLACKVADFG LARLLKDDIY SPSSSSKIPV KWTAPEAANY RVFSQKSDVW SFGVLLHEVF
     TYGQCPYEGM TNHETLQQIM RGYRLPRPAA CPAEVYVLML ECWRSSPEER PSFATLREKL
     HAIHRCHP
//
